Kohjin Bio (177A) · RiskFirst stated
Deterioration in the Profitability of Contract Cell Processing Operations
First written in FY2027-H1. . Latest entry: FY2027-H1.
1entries
1years
0from disclosures
How it moved
Same theme, other companies
Deterioration in the Profitability of Contract Cell Processing OperationsA theme 1 companies write about · 1 as a headwind · 0 as a tailwind
No other company in this theme has enough history to compare yet.